Bio-Techne Corp.

TECH

Bio-Techne Corp. (TECH) is a global leader in the development, manufacturing, and distribution of biotechnology and pharmaceutical products. The company specializes in proteins, antibodies, and reagents used in scientific research, clinical diagnostics, and biopharmaceutical development. Founded in 1980, Bio-Techne serves customers across life sciences, healthcare, and biotech industries, providing innovative solutions to advance scientific discovery and improve healthcare outcomes.

$72.12 +0.40 (0.56%)
Dividend Yield 0.44%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
May 29, 2026$0.082026-05-182026-05-18
February 27, 2026$0.082026-02-132026-02-16
November 28, 2025$0.082025-11-172025-11-17
August 29, 2025$0.082025-08-182025-08-18
May 30, 2025$0.082025-05-192025-05-19

Dividends Summary

Company News

Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders
GlobeNewswire Inc. • Halper Sadeh Llc • July 6, 2026

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offe...

Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer
The Motley Fool • Josh Kohn-Lindquist • June 25, 2026

Bio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies wi...

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
Benzinga • Piero Cingari • May 6, 2026

U.S. equities hit fresh record highs on May 6, 2026, with the S&P 500 and Nasdaq 100 reaching all-time peaks. AMD and Super Micro Computer surged 16% on strong AI-driven earnings, while oil prices collapsed 6-7% on diplomatic hopes between Washington and Tehran. Technology stocks led gains, though energy stocks declined sharply. Mixed earnings re...

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape
GlobeNewswire Inc. • Researchandmarkets.Com • March 20, 2026

The global ELISpot & FluoroSpot assay market is projected to grow at a CAGR of 7.1% from 2025 to 2031, driven by increasing adoption of immunology research techniques, personalized immune therapies, and advanced diagnostic assays. Key growth areas include reagent products, pharmaceutical & biotechnology firms, and the APAC region. Major trends in...

Bio-Techne Declares Dividend
Benzinga • Prnewswire • February 4, 2026

Bio-Techne Corporation (NASDAQ: TECH) announced a quarterly dividend of $0.08 per share for the quarter ended December 31, 2025, payable on February 27, 2026, to shareholders of record on February 16, 2026. The company generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people worldwide.

Related Companies